Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900
Correa-Villasenor A, Ferencz C, Neill CA, Wilson PD, Boughman JA (1994) Ebstein’s malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. Teratology 50:137–147
Article CAS PubMed Google Scholar
Attenhofer Jost CH, Connolly HM, Dearani JA, Edwards WD, Danielson GK (2007) Ebstein’s anomaly. Circulation 115:277–285
Freud LR, Escobar-Diaz MC, Kalish BT, Komarlu R, Puchalski MD, Jaeggi ET, Szwast AL, Freire G, Levasseur SM, Kavanaugh-McHugh A, Michelfelder EC, Moon-Grady AJ, Donofrio MT, Howley LW, Tierney ES, Cuneo BF, Morris SA, Pruetz JD, van der Velde ME, Kovalchin JP, Ikemba CM, Vernon MM, Samai C, Satou GM, Gotteiner NL, Phoon CK, Silverman NH, McElhinney DB, Tworetzky W (2015) Outcomes and predictors of perinatal mortality in fetuses with Ebstein anomaly or tricuspid valve dysplasia in the current era: a multicenter study. Circulation 132:481–489
Article PubMed PubMed Central Google Scholar
Freud LR, McElhinney DB, Kalish BT, Escobar-Diaz MC, Komarlu R, Puchalski MD, Jaeggi ET, Szwast AL, Freire G, Levasseur SM, Kavanaugh-McHugh A, Michelfelder EC, Moon-Grady AJ, Donofrio MT, Howley LW, Selamet Tierney ES, Cuneo BF, Morris SA, Pruetz JD, van der Velde ME, Kovalchin JP, Ikemba CM, Vernon MM, Samai C, Satou GM, Gotteiner NL, Phoon CK, Silverman NH, Tworetzky W (2020) Risk factors for mortality and circulatory outcome among neonates prenatally diagnosed with Ebstein anomaly or tricuspid valve dysplasia: a multicenter study. J Am Heart Assoc 9:e016684
Article PubMed PubMed Central Google Scholar
Goldberg SP, Jones RC, Boston US, Haddad LM, Wetzel GT, Chin TK, Knott-Craig CJ (2011) Current trends in the management of neonates with Ebstein’s anomaly. World J Pediatr Congenit Heart Surg 2:554–557
McElhinney DB, Salvin JW, Colan SD, Thiagarajan R, Crawford EC, Marcus EN, del Nido PJ, Tworetzky W (2005) Improving outcomes in fetuses and neonates with congenital displacement (Ebstein’s malformation) or dysplasia of the tricuspid valve. Am J Cardiol 96:582–586
Wertaschnigg D, Manlhiot C, Jaeggi M, Seed M, Dragulescu A, Schwartz SM, van Arsdell G, Jaeggi ET (2016) Contemporary outcomes and factors associated with mortality after a fetal or neonatal diagnosis of Ebstein anomaly and tricuspid valve disease. Can J Cardiol 32:1500–1506
Luxford JC, Arora N, Ayer JG, Verrall CE, Cole AD, Orr Y, d’Udekem Y, Sholler GF, Winlaw DS (2017) Neonatal Ebstein anomaly: a 30-year institutional review. Semin Thorac Cardiovasc Surg 29:206–212
Matics TJ, Sanchez-Pinto LN (2017) Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically Ill children. JAMA Pediatr 171:e172352
Article PubMed PubMed Central Google Scholar
Andrews RE, Tibby SM, Sharland GK, Simpson JM (2008) Prediction of outcome of tricuspid valve malformations diagnosed during fetal life. Am J Cardiol 101:1046–1050
Celermajer DS, Cullen S, Sullivan ID, Spiegelhalter DJ, Wyse RK, Deanfield JE (1992) Outcome in neonates with Ebstein’s anomaly. J Am Coll Cardiol 19:1041–1046
Article CAS PubMed Google Scholar
Selamet Tierney ES, McElhinney DB, Freud LR, Tworetzky W, Cuneo BF, Escobar-Diaz MC, Ikemba C, Kalish BT, Komarlu R, Levasseur SM, Puchalski MD, Satou GM, Silverman NH, Moon-Grady AJ (2017) Assessment of progressive pathophysiology after early prenatal diagnosis of the Ebstein anomaly or tricuspid valve dysplasia. Am J Cardiol 119:106–111
Hornberger LK, Sahn DJ, Kleinman CS, Copel JA, Reed KL (1991) Tricuspid valve disease with significant tricuspid insufficiency in the fetus: diagnosis and outcome. J Am Coll Cardiol 17:167–173
Article CAS PubMed Google Scholar
Freud LR, Wilkins-Haug LE, Beroukhim RS, LaFranchi T, Phoon CK, Glickstein JS, Cumbermack KM, Makhoul M, Morris SA, Sun HY, Ferrer Q, Pedra SR, Tworetzky W (2021) Effect of In utero non-steroidal anti-inflammatory drug therapy for severe Ebstein anomaly or tricuspid valve dysplasia (NSAID therapy for fetal Ebstein anomaly). Am J Cardiol 141:106–112
Article CAS PubMed Google Scholar
Wald RM, Adatia I, Van Arsdell GS, Hornberger LK (2005) Relation of limiting ductal patency to survival in neonatal Ebstein’s anomaly. Am J Cardiol 96:851–856
Sethi N, Klugman D, Said M, Hom L, Bowers S, Berger JT, Wernovsky G, Donofrio MT (2021) Standardized delivery room management for neonates with a prenatal diagnosis of congenital heart disease: a model for improving interdisciplinary delivery room care. J Neonatal Perinat Med 14:317–329
Thomas AR, Geisser D, Kaza E, Allan C, Abdulhayoglu E, Flanigan E, Dionne A, Kerstein J, Valencia E, Manning S, Goldberg S (2026) Importance of clinical practice guidelines for specialized delivery room resuscitation of newborns with prenatally diagnosed critical congenital heart disease. J Perinatol
Knott-Craig CJ, Overholt ED, Ward KE, Razook JD (2000) Neonatal repair of Ebstein’s anomaly: indications, surgical technique, and medium-term follow-up. Ann Thorac Surg 69:1505–1510
Article CAS PubMed Google Scholar
Reemtsen BL, Starnes VA (2008) Fenestrated right ventricular exclusion (Starnes’ Procedure) for severe neonatal Ebstein’s anomaly. Operative Tech Thorac Cardiovasc Surg 13:91–100
Da Silva JP, Viegas M, Castro-Medina M, Da Fonseca Da Silva L (2020) The Da Silva cone operation after the Starnes procedure for Ebstein’s anomaly: new surgical strategy and initial results. JTCVS Tech 3:281–283
Article PubMed PubMed Central Google Scholar
Konstantinov IE, Chai P, Bacha E, Caldarone CA, Da Silva JP, Da Fonseca Da Silva L, Dearani J, Hornberger L, Knott-Craig C, Del Nido P, Qureshi M, Sarris G, Starnes V, Tsang V (2024) The American Association for Thoracic Surgery (AATS) 2024 expert consensus document: management of neonates and infants with Ebstein anomaly. J Thorac Cardiovasc Surg 168:311–324
Comments (0)